These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39074499)

  • 1. RBE-based dose planning, and calculation of TCP and NTCP with gold nanoparticles for intermediate photon energy in pancreatic cancer.
    Khaledi N; Karshafian R; Taggar AS; Alrabiah K; Khan R; Gräfe JL
    Phys Med Biol; 2024 Aug; 69(17):. PubMed ID: 39074499
    [No Abstract]   [Full Text] [Related]  

  • 2. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.
    Paganetti H
    Acta Oncol; 2017 Nov; 56(11):1379-1386. PubMed ID: 28918679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying a variable relative biological effectiveness (RBE) might affect the analysis of clinical trials comparing photon and proton therapy for prostate cancer.
    Marteinsdottir M; Paganetti H
    Phys Med Biol; 2019 Jun; 64(11):115027. PubMed ID: 31082810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
    Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
    Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).
    Boughalia A; Marcie S; Fellah M; Chami S; Mekki F
    Br J Radiol; 2015 Jun; 88(1050):20140839. PubMed ID: 25882689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC.
    Wang H; Huang Y; Chen H; Shao Y; Duan Y; Feng A; Gu H; Ma X; Xu Z; Kong Q; Zhou Y
    Technol Cancer Res Treat; 2022; 21():15330338221107966. PubMed ID: 35731648
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk adaptive planning with biology-based constraints may lead to higher tumor control probability in tumors of the canine brain: A planning study.
    Radonic S; Schneider U; Besserer J; Meier VS; Rohrer Bley C
    Phys Med; 2024 Mar; 119():103317. PubMed ID: 38430675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
    Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
    Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of potentially variable RBE in liver proton therapy.
    Chen Y; Grassberger C; Li J; Hong TS; Paganetti H
    Phys Med Biol; 2018 Sep; 63(19):195001. PubMed ID: 30183674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
    Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
    Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted dose enhancement in radiotherapy for breast cancer using gold nanoparticles, part 2: A treatment planning study.
    Strigari L; Ferrero V; Visonà G; Dalmasso F; Gobbato A; Cerello P; Visentin S; Attili A
    Med Phys; 2017 May; 44(5):1993-2001. PubMed ID: 28236658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold nanoparticle induced vasculature damage in radiotherapy: Comparing protons, megavoltage photons, and kilovoltage photons.
    Lin Y; Paganetti H; McMahon SJ; Schuemann J
    Med Phys; 2015 Oct; 42(10):5890-902. PubMed ID: 26429263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating different radiotherapy treatment plans, in terms of critical organ scoring index, conformity index, tumor control probability, and normal tissue complication probability calculations in early glottic larynx carcinoma.
    Inal A; Duman E; Ozkan EE
    J Cancer Res Ther; 2020; 16(3):485-493. PubMed ID: 32719255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformal irradiation of concave-shaped PTVs in the treatment of prostate cancer by simple 1D intensity-modulated beams.
    Fiorino C; Broggi S; Corletto D; Cattaneo GM; Calandrino R
    Radiother Oncol; 2000 Apr; 55(1):49-58. PubMed ID: 10788688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-guided adaptive radiation therapy (IGART): Radiobiological and dose escalation considerations for localized carcinoma of the prostate.
    Song W; Schaly B; Bauman G; Battista J; Van Dyk J
    Med Phys; 2005 Jul; 32(7):2193-203. PubMed ID: 16121573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.
    Landry JC; Yang GY; Ting JY; Staley CA; Torres W; Esiashvili N; Davis LW
    Med Dosim; 2002; 27(2):121-9. PubMed ID: 12074463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
    Rana S; Greco K; Samuel EJJ; Bennouna J
    J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer.
    Sukhikh ES; Sukhikh LG; Taletsky AV; Vertinsky AV; Izhevsky PV; Sheino IN
    Phys Med; 2019 Jun; 62():41-46. PubMed ID: 31153397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External photon radiation treatment for prostate cancer: Uncomplicated and cancer-free control probability assessment of 36 plans.
    Sánchez-Nieto B; Romero-Expósito M; Terrón JA; Irazola L; García Hernández MT; Mateos JC; Roselló J; Planes D; Paiusco M; Sánchez-Doblado F
    Phys Med; 2019 Oct; 66():88-96. PubMed ID: 31574423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.